Back to School: How biopharma can reboot drug development. Access exclusive analysis here

European listings 1997

European listings 1997

Company Exchange Comment
Biora, Malmo, Sweden NASDAQ/ Stockholm dual listing

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE